Jasper Therapeutics (JSPRW) Short Interest Ratio & Short Volume $0.13 -0.02 (-11.72%) As of 03:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends Jasper Therapeutics Short Interest DataJasper Therapeutics (JSPRW) has a short interest of 18,000 shares. This marks a 7.14% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 11,645 shares to cover all short positions.Current Short Interest18,000 sharesPrevious Short Interest16,800 sharesChange Vs. Previous Month+7.14%Dollar Volume Sold Short$2,610.00Short Interest Ratio3.1 Days to CoverLast Record DateFebruary 15, 2025Today's Trading Volume246 sharesAverage Trading Volume11,645 sharesToday's Volume Vs. Average2% Short Selling Jasper Therapeutics? Sign up to receive the latest short interest report for Jasper Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartJSPRW Short Interest Over TimeJSPRW Days to Cover Over TimeJSPRW Percentage of Float Shorted Over Time Jasper Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/202518,000 shares $2,610.00 +7.1%N/A3.1 $0.15 1/31/202516,800 shares $2,486.40 -11.1%N/A2.7 $0.15 1/15/202518,900 shares $2,835.00 +11.8%N/A3.2 $0.15 12/31/202416,900 shares $3,542.24 +1.8%N/A4.3 $0.21 12/15/202416,600 shares $3,685.20 +5.7%N/A6.4 $0.22 11/30/202415,700 shares $3,136.86 -4.3%N/A3.8 $0.20 11/15/202416,400 shares $3,050.38 -18.0%N/A3.3 $0.19 10/31/202420,000 shares $3,996.00 +13.0%N/A4.3 $0.20 10/15/202417,700 shares $3,251.49 +1.7%N/A3.8 $0.18 9/30/202417,400 shares $3,480.00 -44.2%N/A3.8 $0.20 Get the Latest News and Ratings for JSPRW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/15/202431,200 shares $5,850.00 +45.8%N/A6.6 $0.19 8/31/202421,400 shares $4,641.66 +34.6%N/A5 $0.22 8/15/202415,900 shares $3,339.00 +51.4%N/A5.9 $0.21 7/31/202410,500 shares $2,283.75 +5.0%N/A2.7 $0.22 7/15/202410,000 shares $2,098.99 -1.0%N/A1.3 $0.21 6/30/202410,100 shares $2,020.00 +21.7%N/A0.8 $0.20 6/15/20248,300 shares $1,722.25 -3.5%N/A0.5 $0.21 5/31/20248,600 shares $1,676.14 +126.3%N/A0.5 $0.19 5/15/20243,800 shares $731.50 -19.2%N/A0.2 $0.19 4/30/20244,700 shares $674.45 -36.5%N/A0.2 $0.14 4/15/20247,400 shares $1,250.60 -8.6%N/A0.3 $0.17 3/31/20248,100 shares $1,474.20 -29.0%N/A0.3 $0.18 3/15/202411,400 shares $1,827.42 -10.9%N/A0.4 $0.16 2/29/202412,800 shares $2,842.88 +0.8%N/A0.5 $0.22 2/15/202412,700 shares $2,286.00 +71.6%N/A0.6 $0.18 1/31/20247,400 shares $740.00 -66.4%N/A0.3 $0.10 1/15/202422,000 shares $1,757.80 -8.3%N/A1 $0.08 12/31/202324,000 shares $1,920.00 +124.3%N/A1.1 $0.08 12/15/202310,700 shares $700.85 -2.7%N/A0.5 $0.07 11/30/202311,000 shares $873.40 -7.6%N/A0.5 $0.08 11/15/202311,900 shares $595.00 +56.6%N/A0.6 $0.05 10/31/20237,600 shares $836.00 -26.2%N/A0.4 $0.11 10/15/202310,300 shares $1,184.50 +51.5%N/A0.8 $0.12 9/30/20236,800 shares $340.00 +47.8%N/A0.5 $0.05 9/15/20234,600 shares $471.96 +18.0%N/A0.9 $0.10 8/31/20233,900 shares $236.34 -45.8%N/A0.8 $0.06 8/15/20237,200 shares $732.24 -20.9%N/A0.7 $0.10 7/31/20239,100 shares $910.00 -49.4%N/A1 $0.10 7/15/202318,000 shares $2,407.73 -2.7%N/A1.9 $0.13 6/30/202318,500 shares $2,594.61 -7.0%N/A1.9 $0.14Texas approves new currency (Ad)Rural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the global banking system... backed up by Elon Musk and the White House.Read about it here. 6/15/202319,900 shares $2,889.48 -21.7%N/A1.5 $0.15 5/31/202325,400 shares $3,550.92 -0.4%N/A1.2 $0.14 5/15/202325,500 shares $4,204.95 No ChangeN/A1.1 $0.16 JSPRW Short Interest - Frequently Asked Questions What is Jasper Therapeutics' current short interest? Short interest is the volume of Jasper Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 15th, traders have sold 18,000 shares of JSPRW short. Learn More on Jasper Therapeutics' current short interest. What is a good short interest ratio for Jasper Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JSPRW shares currently have a short interest ratio of 3.0. Learn More on Jasper Therapeutics's short interest ratio. Is Jasper Therapeutics' short interest increasing or decreasing? Jasper Therapeutics saw a increase in short interest in February. As of February 15th, there was short interest totaling 18,000 shares, an increase of 7.1% from the previous total of 16,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short Jasper Therapeutics stock? Short selling JSPRW is an investing strategy that aims to generate trading profit from Jasper Therapeutics as its price is falling. JSPRW shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Jasper Therapeutics? A short squeeze for Jasper Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JSPRW, which in turn drives the price of the stock up even further. How often is Jasper Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JSPRW, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Interest ALVOW Short Interest BCTXW Short Interest CLNNW Short Interest ENGNW Short Interest FBIOP Short Interest GOVXW Short Interest IMTXW Short Interest LEXXW Short Interest LIXTW Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:JSPRW) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.